|Bid||15.15 x 36900|
|Ask||15.16 x 39400|
|Day's Range||14.37 - 15.08|
|52 Week Range||8.25 - 30.78|
|Beta (5Y Monthly)||1.70|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Feb 04, 2020|
|1y Target Est||N/A|
The already weak air-travel demand is dwindling further due to rise in coronavirus cases in the United States. This implies further trouble for American Airlines (AAL).
Before the economy and struggling stocks completely recover, investors may want to consider buying shares of Merck (NYSE: MRK), JPMorgan Chase (NYSE: JPM), and American Airlines (NASDAQ: AAL), which could be performing a whole lot better a year from now. Healthcare company Merck has had a tough year, mostly because hospitals are deferring procedures and people aren't making their usual trips to the doctor's office. In its earnings release, Merck reported that the pandemic has negatively affected its pharmaceutical revenue to the tune of about $475 million during the past quarter and $2.1 billion since the start of the year.
Is AAL stock a good buy as a Covid-19 vaccine is on the horizon and the 737 Max grounding has been lifted? For the answer, take a look at American's earnings and stock chart.